浙江富潤(600070.SH):擬授予限制性股票1522.5386萬股
格隆匯 3 月 18日丨浙江富潤(600070.SH)發佈2021年限制性股票激勵計劃(草案),擬授予的限制性股票數量為1522.5386萬股,佔公吿時公司股本總額的2.92%。
該激勵計劃採取的激勵工具為限制性股票。股票來源為公司從二級市場回購的公司A股普通股。
該激勵計劃授予的激勵對象總人數為58人,包括公司公吿該激勵計劃時在公司(含子公司,下同)任職的董事、高級管理人員、核心骨幹(技術)人員。
該計劃限制性股票的授予價格為3.29元/股。在本計劃公吿當日至激勵對象完成限制性股票登記期間,若公司發生資本公積轉增股本、派發股票紅利、股份拆細或縮股、配股、派息等事宜,限制性股票的授予價格將做相應的調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.